Minims (Phenylephrine Hydrochloride)

Phenylephrine Hydrochloride, the active ingredient in Minims, is an alpha‑adrenergic agonist presented as a topical ophthalmic solution for ocular use. It is indicated for use in adult patients undergoing ophthalmic procedures where controlled mydriasis and reduction of ocular hyperemia are required.

GNH USA supplies Minims as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to European Union pharmacopeial standards and is manufactured under GMP conditions. Minims is marketed throughout the European Union and exported to other regions.

Phenylephrine Hydrochloride is an alpha‑adrenergic agonist used in ophthalmology to manage pupil size and ocular redness.

- Ophthalmic examination: induces mydriasis to allow thorough retinal and anterior segment evaluation. - Intraocular surgery: provides controlled pupil dilation to facilitate surgical access. - Ocular hyperemia: reduces conjunctival redness for improved visual comfort.

Phenylephrine Hydrochloride may cause ocular and systemic adverse reactions, most of which are mild and transient.

Common Side Effects: - Burning or stinging sensation: mild discomfort upon instillation. - Transient blurred vision: temporary reduction in visual acuity. - Mild conjunctival redness: slight irritation after use. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Increased intraocular pressure: may exacerbate glaucoma. - Systemic hypertension: elevated blood pressure in susceptible individuals. - Cardiac arrhythmia: irregular heart rhythm in patients with cardiovascular disease. - Allergic reaction: rash, swelling, or itching around the eye.

When using Phenylephrine Hydrochloride, certain precautions should be observed to minimize risk. - Contraindication in glaucoma: avoid use in patients with narrow‑angle or uncontrolled glaucoma. - Cardiovascular disease: use cautiously in individuals with hypertension or heart disease. - Pregnancy and lactation: safety not established; prescribe only if benefit outweighs risk. - Pediatric use: not recommended for children without specialist guidance. - Drug interactions: review concomitant alpha‑agonists or MAO inhibitors. - Store at room temperature: keep in original container, protect from light and moisture.

Phenylephrine Hydrochloride can interact with several systemic agents; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may cause severe hypertension. - Tricyclic antidepressants: additive pressor effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may blunt cardiovascular response. - Other sympathomimetics: increase risk of tachycardia. - Antihypertensive agents: may reduce efficacy of blood pressure control.